Corrigendum: Vascular Endothelial (VE)-Cadherin, Endothelial Adherens Junctions, and Vascular Disease.
作者信息
Lampugnani Maria Grazia, Dejana Elisabetta, Giampietro Costanza
出版信息
Cold Spring Harb Perspect Biol. 2017 Oct 3;9(10):a033720. doi: 10.1101/cshperspect.a033720.
Abstract
摘要
相似文献
1
Corrigendum: Vascular Endothelial (VE)-Cadherin, Endothelial Adherens Junctions, and Vascular Disease.
Cold Spring Harb Perspect Biol. 2017 Oct 3;9(10):a033720. doi: 10.1101/cshperspect.a033720.
2
CMTM3 (CKLF-Like Marvel Transmembrane Domain 3) Mediates Angiogenesis by Regulating Cell Surface Availability of VE-Cadherin in Endothelial Adherens Junctions.
Arterioscler Thromb Vasc Biol. 2017 Jun;37(6):1098-1114. doi: 10.1161/ATVBAHA.116.308792. Epub 2017 Apr 20.
3
4
Dynamic Regulation of Vascular Permeability by Vascular Endothelial Cadherin-Mediated Endothelial Cell-Cell Junctions.
J Nippon Med Sch. 2017;84(4):148-159. doi: 10.1272/jnms.84.148.
5
A local VE-cadherin and Trio-based signaling complex stabilizes endothelial junctions through Rac1.
J Cell Sci. 2015 Aug 15;128(16):3041-54. doi: 10.1242/jcs.168674. Epub 2015 Jun 26.
6
VE-cadherin and endothelial adherens junctions: active guardians of vascular integrity.
Dev Cell. 2013 Sep 16;26(5):441-54. doi: 10.1016/j.devcel.2013.08.020.
7
VE-cadherin complex plasticity: EPS8 and YAP play relay at adherens junctions.
Tissue Barriers. 2016 Sep 3;4(4):e1232024. doi: 10.1080/21688370.2016.1232024. eCollection 2016.
8
Beyond vessels: occurrence and regional clustering of vascular endothelial (VE-)cadherin-containing junctions in non-endothelial cells.
Cell Tissue Res. 2009 Jan;335(1):49-65. doi: 10.1007/s00441-008-0718-1. Epub 2008 Nov 11.
9
Gαs Relays Sphingosine-1-Phosphate Receptor 1 Signaling to Stabilize Vascular Endothelial-Cadherin at Endothelial Junctions to Control Mouse Embryonic Vascular Integrity.
J Genet Genomics. 2015 Nov 20;42(11):613-624. doi: 10.1016/j.jgg.2015.08.006. Epub 2015 Oct 20.
10
Differential impairment of adherens-junction expression/phosphorylation after cardioplegia in diabetic versus non-diabetic patients.
Eur J Cardiothorac Surg. 2016 Mar;49(3):937-43. doi: 10.1093/ejcts/ezv202. Epub 2015 Jun 11.
引用本文的文献
1
Reversal of pulmonary veno-occlusive disease phenotypes by inhibition of the integrated stress response.
Nat Cardiovasc Res. 2024 Jul;3(7):799-818. doi: 10.1038/s44161-024-00495-z. Epub 2024 Jul 9.
2
Novel Regioisomeric Analogues of Naphthyl--Acylhydrazone Derivatives and Their Anti-Inflammatory Effects.
Int J Mol Sci. 2022 Nov 5;23(21):13562. doi: 10.3390/ijms232113562.
3
Control of dynamic cell behaviors during angiogenesis and anastomosis by Rasip1.
Development. 2021 Aug 1;148(15). doi: 10.1242/dev.197509. Epub 2021 Aug 12.
4
Organotypic primary blood vessel models of clear cell renal cell carcinoma for single-patient clinical trials.
Lab Chip. 2020 Nov 24;20(23):4420-4432. doi: 10.1039/d0lc00252f.
5
Matrix stiffness regulates vascular integrity through focal adhesion kinase activity.
FASEB J. 2019 Jan;33(1):1199-1208. doi: 10.1096/fj.201800841R. Epub 2018 Aug 13.
6
Septins regulate junctional integrity of endothelial monolayers.
Mol Biol Cell. 2018 Jul 15;29(13):1693-1703. doi: 10.1091/mbc.E18-02-0136. Epub 2018 May 17.
本文引用的文献
1
The cerebral cavernous malformation proteins CCM2L and CCM2 prevent the activation of the MAP kinase MEKK3.
Proc Natl Acad Sci U S A. 2015 Nov 17;112(46):14284-9. doi: 10.1073/pnas.1510495112. Epub 2015 Nov 4.
Zotero 插件